Melatonin and Alzheimer's disease

Arushanian É.B.

doi:https://doi.org/

Arushanian É.B.

Kafedra farmakologii Stavropol'skoĭ gosudarstvennoĭ meditsinskoĭ akademii

Melatonin and Alzheimer's disease

Authors:

Arushanian É.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(1): 100‑106

Read: 6779 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Arushanian ÉB. Melatonin and Alzheimer's disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(1):100‑106. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Cytokine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12

Curcumin-induced increased retinal fluorescence as a new method in the early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):19-25

Differential diagnosis of Alzheimer’s disease and vascular cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35

A comprehensive study of Alzheimer’s disease biomarkers in plasma and cerebrospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53

Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60

Novel prospects for early diagnosis of cognitive impairment using Eye-tracking technology. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):13-20

Angiotensin model as a new approach to study of mesenchymal stem cell senescence. Russian Cardiology Bulletin. 2025;(2):20-26

Comparative analysis of preventive action of drinking sulfate mineral water on neurohormonal and immune regulation organs in radiation exposure to rats. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(2):45-51

Potential and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medicine. 2025;(7):94-99

Associations between salivary melatonin and periodontal disease: a systematic review and meta-analysis. Stomatology. 2025;(3):87-96

Abstract:

We studied anti-acetylcholine receptor antibodies (ARAb) in 25 patients with myasthenia gravis before and after the immunosuppressive drug (steroid) therapy and in 22 patients before and after thymectomy. The clinical effect after the treatment was correlated with the reduction of ARAb levels by more than 20% in 62% of patients. The ARAb levels did not change, or even increased, in 15% patients despite the improvement of their clinical state. We showed the direct correlation between the clinical improvement and the decrease of ARAb level.

Keywords:

Alzheimer's disease

pineal gland (epiphisis)

melatonin

Authors:

Arushanian É.B.

Kafedra farmakologii Stavropol'skoĭ gosudarstvennoĭ meditsinskoĭ akademii

Close metadata

References:

Akarachkova E.S. Primenenie «Magne-V6» v shirokoi terapevticheskoi praktike. Trudnyi patsient 2007;5:48-54.
Akarachkova E.S. «Klinicheskie proyavleniya dezadaptatsii i defitsita magniya u zhenshchin starshe 40 let». Materialy nauchno-prakticheskoi konferentsii ginekologov MMA: «Zdorov'e zhenshchiny posle 40 let». 29-30 maya 2008. M 2008.
Akarachkova E.S. Asteniya: kharakteristika, sovremennye sredstva dlya lecheniya. Novaya apteka 2008;9.
Akarachkova E.S., Drobizhev M.Yu., Vorob'eva O.V., Makukh E.A. Nespetsificheskaya bol' i depressiya v nevrologii. Zhurn nevrol i psikhiat 2008;12:4-10.
Akarachkova E.S., Drobizhev M.Yu., Makukh E.A. Asteniya i depressiya u bol'nykh v nevrologicheskoi praktike. Lechenie nervnykh boleznei 2008;3:25:35-41.
Akarachkova E.S. Blokatory kal'tsievykh kanalov v nevrologicheskoi praktike. Vrach 2009;9:35-39.
Vorob'eva O.V., Akarachkova E.S. Magne V6: opyt 5-letnego klinicheskogo primeneniya v nevrologicheskoi i terapevticheskoi praktike. Farmateka 2008;20:73-80.
Gromova O.A. Magnii i piridoksin: osnovy znanii. M 2006;223.
Damulin I.V. Umerennye kognitivnye rasstroistva: nekotorye patogeneticheskie, klinicheskie i terapevticheskie aspekty. Consillium Medicum 2008;2:19-24.
Doskin V.A., Lavrent'ev N.A., Miroshnikov M.P., Sharai V.B. 1 MMI 1973.
Marri R., Grenner D., Roduell V. Biokhimiya cheloveka: v 2 t. T 2. Per. s angl. M: Mir 1993;415.
Patofiziologiya. Kurs lektsii: Uchebnoe posobie. M 1995;752.
Shvarkov S.B., Akarachkova E.S. Korrektsii energeticheskogo i elektrolitnogo balansa preparatami magniya i piridoksina pri nevrologicheskikh zabolevaniyakh. Med tekhnol 2007;31.
Ax S., Gregg V.H., Jones D. Chronic fatigue syndrome: sufferers’ evaluation of medical support. J R Soc Med 1997;90:250-254.
Aydin H., Deyneli O., Yavuz D. et al. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res 2010;133:2:136-143.
Barbagallo M., Belvedere M., Dominguez L.J. Magnesium homeostasis and aging. Magnes Res 2009;22:4:235-246.
Day R., Liauw W. et al. A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenopausal women. BMC Res Not 2010;3:180.
Eby G.A., Eby K.L. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypothes 2010;74:4:649-660.
Fukuda K., Straus S.E., Hickie I. et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med 1994;121:953-959.
Hadjistavri L.S., Sarafidis P.A., Georgianos P.I. et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010;16:6:307-312.
Jacka F.N., Overland S., Stewart R. et al. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. New Zealand J Psychiat 2009;43:1:45-52.
Jorgensen R. Chronic fatigue: an evolutionary concept analysis. J Adv Nurs 2008;63:2:199-207.
Lane R.J., Soteriou B.A., Zhang H., Archard L.C. Enterovirus related metabolic myopathy: a postviral fatigue syndrome. J Neurol Neurosurg Psychiat 2003;74:10:1382-1386.
Nechifor M. Interactions between magnesium and psychotropic drugs. Magnes Res 2008;21:2:97-100.
Nechifor M. Magnesium in major depression. Magnes Res 2009;22:3:163-166.
Nisenbaum R., Jones J., Unger E. et al. A population-based study of the clinical course of chronic fatigue syndrome. Health Qualit Life Outcomes 2003;1:49.
Pokan R., Hofmann P., von Duvillard S.P. et al. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med 2006;40:9:773-778.
Prins J.B., Bleijenberg G., Klein Rouweler E. et al. Doctor-patient relationship in primary care of chronic fatigue syndrome: perspectives of the doctor and the patient. J CFS 2000;7:3-15.
Solomon L., Nisenbaum R., Reyes M. et al. Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population. Health Qualit Life Outcomes 2003;1:48.
Spasov A.A., Iezhitsa I.N., Kharitonova M.V., Kravchenko M.S. Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet. Zhurn vysshei nervnoi deyatel'nosti 2008;58:4:476-485.